Allergy Therapeutics plc (AIM: AGY)
Health Care · Pharmaceuticals · GB
£0.05
-2.86% today · -41.4% 1Y
Allergy Therapeutics plc (AIM: AGY) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $440.19M.
Over the last twelve months the share price has lost 41.4%, trading between 0.05 and 0.12.
Tweenvest scores Allergy Therapeutics plc across four factors: quality 42/100, value 45/100, growth 0/100. Its strongest factor is value.
AGY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $440.19M
- Revenue (TTM)
- $77.11M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.84
- 52-week high
- £0.12
- 52-week low
- £0.05
- Avg volume (3M)
- —
- Shares outstanding
- 6.33B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.